# EAVE II Analysis Repository
## COVID-19 vaccines and thromboembolic, thrombocytopenia and hemorrhagic events 

### Paper Details
> **Short title:** Covid-Safety-haemo
>
>**DOI:** [Insert DOI of paper here]
>
>**Paper authors:** [Insert the top 6 authors of paper (followed by ‘et al’ if more) here]
>
>**Data source:** [Insert link to data source (if publicly available) here]

### Funding
This analysis is part of the Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II) study. EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE - The Health Data Research Hub for Respiratory Health [MC_PC_19004], which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support has been provided through the Scottish Government DG Health and Social Care.  
[Insert any other funding information on paper here]
